Internal Medicine, Hematology & Oncology · Salt Lake City, UT
NPI
1942444609
Since 2009
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1950 Circle of Hope Dr
Salt Lake City, UT, 84112
Phone (801) 213-3800
Groups this clinician bills Medicare through
Medicare paid, 2024
$63K
1,047 services
Medicare patients, 2024
214
Average age 73
Drug cost, 2024
$7.1M
1,397 prescriptions
Company payments, 2025
$163K
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Douglas W Sborov was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 220 times for 124 patients. In total Douglas W Sborov billed 1,047 services in 14 codes, and Medicare paid $63K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-17.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 220 | 124 | $12.71 | $2,797 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 190 | 109 | $12.55 | $2,385 |
| 99215 Office E&M - Established | Facility | 163 | 94 | $108.07 | $18K |
| 99215 Office E&M - Established | Office | 136 | 77 | $136.16 | $19K |
| 99214 Office E&M - Established | Office | 99 | 76 | $88.96 | $8,807 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 53 | 24 | $24.12 | $1,278 |
| 99214 Office E&M - Established | Facility | 47 | 40 | $63.72 | $2,995 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 42 | 26 | $25.28 | $1,062 |
| 99233 Hospital E&M - Subsequent | Facility | 25 | 11 | $86.18 | $2,154 |
| 99205 Office E&M - New | Office | 17 | 17 | $171.28 | $2,912 |
By year: 2022 $49K for 550 services; 2023 $64K for 751 services; 2024 $63K for 1,047 services.
Medicare prescription drug claims, 2024
In 2024, the drug Douglas W Sborov prescribed most often to Medicare patients was Acyclovir, with 338 prescriptions and refills. In total Douglas W Sborov wrote 1,397 Medicare prescriptions that cost $7.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 338 | 536 | 80 | $5,166 |
| Revlimid Lenalidomide | 260 | 260 | 43 | $4.2M |
| Pomalyst Pomalidomide | 96 | 96 | 18 | $1.9M |
| Eliquis Apixaban | 94 | 134 | 18 | $77K |
| Dexamethasone Generic | 75 | 80 | 30 | $1,009 |
| Omeprazole Generic | 70 | 135 | 23 | $794 |
| Famotidine Generic | 36 | 84 | Under 11 | $344 |
| Gabapentin Generic | 35 | 70 | 13 | $576 |
| Ondansetron Hcl Generic | 27 | 27 | 16 | $165 |
| Xarelto Rivaroxaban | 24 | 31 | Under 11 | $18K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 20 | 30 | 11 | $101 |
| Levothyroxine Sodium Generic | 19 | 25 | Under 11 | $82.64 |
| Xpovio Selinexor | 18 | 18 | Under 11 | $484K |
| Levofloxacin Generic | 17 | 17 | Under 11 | $60.61 |
| Potassium Chloride Generic | 17 | 38 | Under 11 | $221 |
Brand drugs: 555 claims; generic drugs: 842 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Douglas W Sborov $163K ($163K in general payments such as food, travel and fees) from 19 companies. The largest payer was GlaxoSmithKline, LLC. with $128K.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 4 | $128K |
| Regeneron Healthcare Solutions, Inc. REGN | 15 | $13K |
| Pfizer Inc. PFE | 6 | $12K |
| Legend Biotech USA Inc. LEGN | 5 | $4,022 |
| Janssen Scientific Affairs, LLC JNJ | 4 | $3,390 |
| Janssen Biotech, Inc. JNJ | 6 | $2,348 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $103 |
| Menarini Silicon Biosystems, Inc. | 1 | $79.8 |
| Genzyme Corporation SNY | 1 | $60.63 |
| Celgene Corporation BMY | 1 | $56.02 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.